全文获取类型
收费全文 | 6557篇 |
免费 | 574篇 |
国内免费 | 103篇 |
专业分类
耳鼻咽喉 | 50篇 |
儿科学 | 121篇 |
妇产科学 | 301篇 |
基础医学 | 786篇 |
口腔科学 | 137篇 |
临床医学 | 756篇 |
内科学 | 1488篇 |
皮肤病学 | 80篇 |
神经病学 | 640篇 |
特种医学 | 337篇 |
外科学 | 726篇 |
综合类 | 167篇 |
一般理论 | 2篇 |
预防医学 | 377篇 |
眼科学 | 177篇 |
药学 | 393篇 |
中国医学 | 70篇 |
肿瘤学 | 626篇 |
出版年
2023年 | 45篇 |
2022年 | 88篇 |
2021年 | 166篇 |
2020年 | 93篇 |
2019年 | 191篇 |
2018年 | 215篇 |
2017年 | 173篇 |
2016年 | 194篇 |
2015年 | 252篇 |
2014年 | 289篇 |
2013年 | 371篇 |
2012年 | 493篇 |
2011年 | 508篇 |
2010年 | 332篇 |
2009年 | 300篇 |
2008年 | 357篇 |
2007年 | 332篇 |
2006年 | 381篇 |
2005年 | 295篇 |
2004年 | 288篇 |
2003年 | 257篇 |
2002年 | 210篇 |
2001年 | 162篇 |
2000年 | 145篇 |
1999年 | 122篇 |
1998年 | 54篇 |
1997年 | 51篇 |
1996年 | 41篇 |
1995年 | 22篇 |
1994年 | 26篇 |
1993年 | 27篇 |
1992年 | 73篇 |
1991年 | 74篇 |
1990年 | 58篇 |
1989年 | 63篇 |
1988年 | 39篇 |
1987年 | 38篇 |
1986年 | 48篇 |
1985年 | 35篇 |
1984年 | 30篇 |
1983年 | 33篇 |
1982年 | 24篇 |
1981年 | 22篇 |
1979年 | 20篇 |
1978年 | 19篇 |
1977年 | 16篇 |
1975年 | 14篇 |
1974年 | 30篇 |
1973年 | 21篇 |
1972年 | 18篇 |
排序方式: 共有7234条查询结果,搜索用时 31 毫秒
71.
CIP2A is a poor prognostic factor and can be a diagnostic marker in papillary thyroid carcinoma 下载免费PDF全文
Ting‐Ting Chao Hung‐Chune Maa Cheng‐Yi Wang Dee Pei Yao‐Jen Liang Yi‐Feng Yang Shuo‐Jiun Chou Yen‐Lin Chen 《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》2016,124(12):1031-1037
Papillary thyroid carcinoma (PTC) is the most common type of thyroid carcinoma. CIP2A has recently been described as a prognostic marker in many cancers. In this study, we assessed the value of this novel prognostic marker in PTC. A total of 178 surgical specimens of both benign and malignant thyroid tumors were collected. Immunohistochemical staining for CIP2A, HBME‐1, galectin‐3, and CK19 was performed. Western blotting for CIP2A was also performed. CIP2A was expressed in 85.3% of malignant tumors and 12.1% of benign tumors. ROC analysis showed that the AUC for CIP2A was higher than those for other tumor markers. Western blotting showed that CIP2A expression was higher in PTC than in other tumors. Poor progression‐free survival was observed in the high‐CIP2A expression group. High CIP2A expression is a poor prognostic factor and can be a diagnostic marker in PTC. The presence of any two of the three indicated makers (CIP2A, galectin‐3, and HBME‐1) is strongly correlated with the diagnosis of PTC. 相似文献
72.
Chia-Ying Lee Huei-ling Yen Pei-wen Yeh Wan-Hsuan Lin Ying-Ying Cheng Yu-Lin Tzeng Hsin-Chi Wu 《Neuropsychologia》2012,50(14):3228-3239
The present study investigates how age, phonological saliency, and deviance size affect the presence of mismatch negativity (MMN) and positive mismatch response (P-MMR). This work measured the auditory mismatch responses to Mandarin lexical tones, initial consonants, and vowels in 4- to 6-year-old preschoolers using the multiple-deviant oddball paradigm. The data showed the coexistence of MMN and P-MMR in the same age group when responding to the three types of syllabic features in Mandarin. The transition from a predominantly positive response to a predominantly negative response supported the multiple MMN mechanisms. Congruent with the phonological saliency hypothesis and the phonetic acquisition order of Mandarin in behavioral studies, for the compulsory elements of Mandarin syllables, lexical tones, and vowels, the larger deviants elicited adult-like MMNs, whereas the smaller deviants elicited P-MMRs. The optional elements of the Mandarin syllables, the initial consonant, only elicited P-MMR in preschoolers. These findings suggest that MMN and P-MMR index different functional characteristics and may provide information on when and how children's speech perception becomes automatic at different developmental stages. 相似文献
73.
74.
Hong‐Hwa Chen Christopher G. Wallace Yen‐Ta Chen Chih‐Chao Yang Steve Leu Yi‐Ching Chen Cheuk‐Kwan Sun Tzu‐Hsien Tsai Yung‐Lung Chen Sheng‐Ying Chung Hon‐Kan Yip 《Journal of pineal research》2014,57(1):16-32
This study tested whether combined therapy with melatonin and apoptotic adipose‐derived mesenchymal stem cells (A‐ADMSCs) offered additional benefit in ameliorating sepsis‐induced acute kidney injury. Adult male Sprague–Dawley rats (n = 65) were randomized equally into five groups: Sham controls (SC), sepsis induced by cecal‐ligation and puncture (CLP), CLP‐melatonin, CLP‐A‐ADMSC, and CLP‐melatonin‐A‐ADMSC. Circulating TNF‐α level at post‐CLP 6 hr was highest in CLP and lowest in SC groups, higher in CLP‐melatonin than in CLP‐A‐ADMSC and CLP‐melatonin‐A‐ADMSC groups (all P < 0.001). Immune reactivity as reflected in the number of splenic helper‐, cytoxic‐, and regulatory‐T cells at post‐CLP 72 hr exhibited the same pattern as that of circulating TNF‐α among all groups (P < 0.001). The histological scoring of kidney injury and the number of F4/80+ and CD14+ cells in kidney were highest in CLP and lowest in SC groups, higher in CLP‐melatonin than in CLP‐A‐ADMSC and CLP‐melatonin‐A‐ADMSC groups, and higher in CLP‐A‐ADMSC than in CLP‐melatonin‐A‐ADMSC groups (all P < 0.001). Changes in protein expressions of inflammatory (RANTES, TNF‐1α, NF‐κB, MMP‐9, MIP‐1, IL‐1β), apoptotic (cleaved caspase 3 and PARP, mitochondrial Bax), fibrotic (Smad3, TGF‐β) markers, reactive‐oxygen‐species (NOX‐1, NOX‐2), and oxidative stress displayed a pattern identical to that of kidney injury score among the five groups (all P < 0.001). Expressions of antioxidants (GR+, GPx+, HO‐1, NQO‐1+) were lowest in SC group and highest in CLP‐melatonin‐A‐ADMSC group, lower in CLP than in CLP‐melatonin and CLP‐A‐ADMSC groups, and lower in CLP‐melatonin‐ than in CLP‐A‐ADMSC‐tretaed animals (all P < 0.001). In conclusion, combined treatment with melatonin and A‐ADMSC was superior to A‐ADMSC alone in protecting the kidneys from sepsis‐induced injury. 相似文献
75.
76.
Lichen nitidus (LN) is an uncommon dermatosis of unknown etiology. LN confined to the palms is an unusual presentation and only a few cases have been reported. The clinical features may mimic pompholyx, pitted keratosis, and porokeratotic eccrine ostial and dermal duct nevus. We herein report a rare case of palmar purpuric LN with characteristic dermoscopic findings. 相似文献
77.
78.
Huei‐Chieh Chuang Pei‐Han Kao Yen‐Lin Huang Li-Yu Lee Tseng‐tong Kuo 《Journal of cutaneous pathology》2014,41(6):509-512
Nevus sebaceus is known to have the potential to develop into various secondary tumors. We observed a sebaceoma arising from a nevus sebaceus excised from the left cheek of a 51‐year‐old woman. This sebaceoma showed desmoplastic change similar to that observed in desmoplastic trichoepithelioma and desmoplastic trichilemmoma. This heretofore undescribed desmoplastic variant of sebaceoma should not be mistaken for invasive sebaceous carcinoma. 相似文献
79.
Raivo Uibo Kai Kisand Chen‐Yen Yang M. Eric Gershwin 《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》2012,120(11):857-871
Primary biliary cirrhosis (PBC) is considered a model autoimmune disease based on several features, including the presence of a highly directed and very specific immune response to mitochondrial autoantigens, a female predominance, a targeted destruction of the biliary epithelium, and homogeneity between patients. It is essentially a chronic progressive cholestatic liver disease characterized by immune‐mediated destruction of small‐ and medium‐sized intrahepatic bile ducts. There is considerable variation in the incidence and prevalence of the disease between regions of the world, although such differences likely reflect not only a true disparity in disease but also differences in awareness; for example, in the United States, PBC is often detected in an asymptomatic stage based on multi‐phasic clinical testing. There has been considerable progress at defining the immune response in this disease, including quantitation of autoreactive T cells against PDC‐E2, the major mitochondrial autoantigen. The overwhelming data suggests that patients develop PBC based on a genetic predisposition and loss of tolerance to one or more environmental agents. In this review, we will present an updated overview of PBC and place it in the context of autoimmunity. 相似文献
80.
Andrew X. Zhu Richard S. Finn Yoon-Koo Kang Chia-Jui Yen Peter R. Galle Josep M. Llovet Eric Assenat Giovanni Brandi Kenta Motomura Izumi Ohno Bruno Daniele Arndt Vogel Tatsuya Yamashita Chih-Hung Hsu Guido Gerken John Bilbruck Yanzhi Hsu Kun Liang Ryan C. Widau Chunxiao Wang Paolo Abada Masatoshi Kudo 《British journal of cancer》2021,124(8):1388
Background Post hoc analyses assessed the prognostic and predictive value of baseline alpha-fetoprotein (AFP), as well as clinical outcomes by AFP response or progression, during treatment in two placebo-controlled trials (REACH, REACH-2).Methods Serum AFP was measured at baseline and every three cycles. The prognostic and predictive value of baseline AFP was assessed by Cox regression models and Subpopulation Treatment Effect Pattern Plot method. Associations between AFP (≥ 20% increase) and radiographic progression and efficacy were assessed.Results Baseline AFP was confirmed as a continuous (REACH, REACH-2; p < 0.0001) and dichotomous (≥400 vs. <400 ng/ml; REACH, p < 0.01) prognostic factor, and was predictive for ramucirumab survival benefit in REACH (p = 0.0042 continuous; p < 0.0001 dichotomous). Time to AFP (hazard ratio [HR] 0.513; p < 0.0001) and radiographic (HR 0.549; p < 0.0001) progression favoured ramucirumab. Association between AFP and radiographic progression was shown for up to 6 (odds ratio [OR] 5.1; p < 0.0001) and 6–12 weeks (OR 1.8; p = 0.0065). AFP response was higher with ramucirumab vs. placebo (p < 0.0001). Survival was longer in patients with an AFP response than patients without (13.6 vs. 5.6 months, HR 0.451; 95% confidence interval, 0.354–0.574; p < 0.0001).Conclusions AFP is an important prognostic factor and a predictive biomarker for ramucirumab survival benefit. AFP ≥ 400 ng/ml is an appropriate selection criterion for ramucirumab.Clinical Trial Registration ClinicalTrials.gov, REACH () and REACH-2 ( NCT01140347).Subject terms: NCT02435433Oncology, Biomarkers 相似文献